These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11289137)

  • 1. Bisphosphonate treatment inhibits the growth of prostate cancer cells.
    Lee MV; Fong EM; Singer FR; Guenette RS
    Cancer Res; 2001 Mar; 61(6):2602-8. PubMed ID: 11289137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitrogen containing bisphosphonates induce apoptosis and inhibit the mevalonate pathway, impairing Ras membrane localization in prostate cancer cells.
    Oades GM; Senaratne SG; Clarke IA; Kirby RS; Colston KW
    J Urol; 2003 Jul; 170(1):246-52. PubMed ID: 12796698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytostatic and apoptotic effects of bisphosphonates on prostate cancer cells.
    Dumon JC; Journé F; Kheddoumi N; Lagneaux L; Body JJ
    Eur Urol; 2004 Apr; 45(4):521-8; discussion 528-9. PubMed ID: 15041119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zoledronate is a potent inhibitor of myeloma cell growth and secretion of IL-6 and MMP-1 by the tumoral environment.
    Derenne S; Amiot M; Barillé S; Collette M; Robillard N; Berthaud P; Harousseau JL; Bataille R
    J Bone Miner Res; 1999 Dec; 14(12):2048-56. PubMed ID: 10620064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts.
    Reinholz GG; Getz B; Pederson L; Sanders ES; Subramaniam M; Ingle JN; Spelsberg TC
    Cancer Res; 2000 Nov; 60(21):6001-7. PubMed ID: 11085520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indirect antitumor effects of bisphosphonates on prostatic LNCaP cells co-cultured with bone cells.
    Tanaka T; Kawashima H; Ohnishi K; Matsumura K; Yoshimura R; Matsuyama M; Kuratsukuri K; Nakatani T
    Anticancer Res; 2009 Apr; 29(4):1089-94. PubMed ID: 19414350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bisphosphonate olpadronate inhibits skeletal prostate cancer progression in a green fluorescent protein nude mouse model.
    Yang M; Burton DW; Geller J; Hillegonds DJ; Hastings RH; Deftos LJ; Hoffman RM
    Clin Cancer Res; 2006 Apr; 12(8):2602-6. PubMed ID: 16638872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential inhibition of invasion and proliferation by bisphosphonates: anti-metastatic potential of Zoledronic acid in prostate cancer.
    Montague R; Hart CA; George NJ; Ramani VA; Brown MD; Clarke NW
    Eur Urol; 2004 Sep; 46(3):389-401; discussion 401-2. PubMed ID: 15306113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonates for cancer patients: why, how, and when?
    Body JJ; Mancini I
    Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the mevalonate pathway and activation of p38 MAP kinase are independently regulated by nitrogen-containing bisphosphonates in breast cancer cells.
    Merrell MA; Wakchoure S; Lehenkari PP; Harris KW; Selander KS
    Eur J Pharmacol; 2007 Sep; 570(1-3):27-37. PubMed ID: 17640631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of bone.
    Cheng YY; Huang L; Lee KM; Xu JK; Zheng MH; Kumta SM
    Calcif Tissue Int; 2004 Jul; 75(1):71-7. PubMed ID: 15037971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells.
    Goffinet M; Thoulouzan M; Pradines A; Lajoie-Mazenc I; Weinbaum C; Faye JC; Séronie-Vivien S
    BMC Cancer; 2006 Mar; 6():60. PubMed ID: 16539721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor effects of bisphosphonates.
    Green JR
    Cancer; 2003 Feb; 97(3 Suppl):840-7. PubMed ID: 12548584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts.
    Samsel L; Zaidel G; Drumgoole HM; Jelovac D; Drachenberg C; Rhee JG; Brodie AM; Bielawska A; Smyth MJ
    Prostate; 2004 Mar; 58(4):382-93. PubMed ID: 14968439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bisphosphonate YM529 inhibits osteolytic and osteoblastic changes and CXCR-4-induced invasion in prostate cancer.
    Miwa S; Mizokami A; Keller ET; Taichman R; Zhang J; Namiki M
    Cancer Res; 2005 Oct; 65(19):8818-25. PubMed ID: 16204052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of mammalian lignans on the growth of prostate cancer cell lines.
    Lin X; Switzer BR; Demark-Wahnefried W
    Anticancer Res; 2001; 21(6A):3995-9. PubMed ID: 11911282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pamidronate inhibits antiapoptotic bcl-2 expression through inhibition of the mevalonate pathway in prostate cancer PC-3 cells.
    Iguchi K; Tatsuda Y; Usui S; Hirano K
    Eur J Pharmacol; 2010 Sep; 641(1):35-40. PubMed ID: 20519142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2-Methoxyestradiol induces G2/M arrest and apoptosis in prostate cancer.
    Qadan LR; Perez-Stable CM; Anderson C; D'Ippolito G; Herron A; Howard GA; Roos BA
    Biochem Biophys Res Commun; 2001 Aug; 285(5):1259-66. PubMed ID: 11478793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skeletal complications of prostate cancer: pathophysiology and therapeutic potential of bisphosphonates.
    Green JR
    Acta Oncol; 2005; 44(3):282-92. PubMed ID: 16076701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer.
    Corey E; Brown LG; Quinn JE; Poot M; Roudier MP; Higano CS; Vessella RL
    Clin Cancer Res; 2003 Jan; 9(1):295-306. PubMed ID: 12538482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.